Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Medicon Hellas stock price, quote, forecast and news

MEDIC.AT
GRS424003002

Price

2.49
Today +/-
+0
Today %
+0 %
P

Medicon Hellas stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Medicon Hellas stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Medicon Hellas stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Medicon Hellas stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Medicon Hellas's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Medicon Hellas Stock Price History

DateMedicon Hellas Price
9/11/20242.49 undefined
9/10/20242.49 undefined
9/6/20242.50 undefined
9/5/20242.52 undefined
9/4/20242.46 undefined
9/3/20242.44 undefined
9/2/20242.36 undefined
8/30/20242.35 undefined
8/29/20242.35 undefined
8/28/20242.36 undefined
8/27/20242.36 undefined
8/26/20242.31 undefined
8/23/20242.39 undefined
8/22/20242.42 undefined
8/21/20242.41 undefined
8/20/20242.48 undefined
8/19/20242.44 undefined
8/16/20242.51 undefined

Medicon Hellas Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Medicon Hellas, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medicon Hellas from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medicon Hellas’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medicon Hellas. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medicon Hellas’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medicon Hellas’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medicon Hellas’s growth potential.

Medicon Hellas Revenue, EBIT and net profit per share

DateMedicon Hellas RevenueMedicon Hellas EBITMedicon Hellas Net Income
202220.77 M undefined3.84 M undefined2.53 M undefined
202121.51 M undefined4.93 M undefined3.04 M undefined
202015.27 M undefined1.59 M undefined756,600 undefined
201913.45 M undefined1.1 M undefined775,170 undefined
201813.77 M undefined2.24 M undefined1.83 M undefined
201712.7 M undefined1.94 M undefined1.72 M undefined
201613.01 M undefined2.88 M undefined1.17 M undefined
201511.46 M undefined2.4 M undefined1.67 M undefined
201411.03 M undefined1.5 M undefined699,380 undefined
201311.4 M undefined1.99 M undefined90,000 undefined
201211.75 M undefined820,000 undefined-530,000 undefined
201114.74 M undefined2.55 M undefined-11.73 M undefined
201016.09 M undefined2.88 M undefined-770,000 undefined
200918.19 M undefined3.58 M undefined1.84 M undefined
200819.74 M undefined3.85 M undefined1.34 M undefined
200719.31 M undefined3.96 M undefined1.58 M undefined
200618.24 M undefined3.87 M undefined1.54 M undefined
200517.98 M undefined3.54 M undefined1.52 M undefined
200418.97 M undefined3.84 M undefined1.5 M undefined
200317.29 M undefined4.7 M undefined2.99 M undefined

Medicon Hellas Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
200220032004200520062007200820092010201120122013201420152016201720182019202020212022
141718171819191816141111111113121313152120
-21.435.88-5.565.885.56--5.26-11.11-12.50-21.43---18.18-7.698.33-15.3840.00-4.76
71.4370.5966.6776.4766.6768.4268.4272.2275.0078.5772.7372.7372.7372.7369.2375.0076.9276.9273.3371.4375.00
101212131213131312118888991010111515
343333332201122121143
21.4323.5316.6717.6516.6715.7915.7916.6712.5014.29-9.099.0918.1815.388.3315.387.696.6719.0515.00
221111110-1100011110032
---50.00------------------33.33
4.184.184.184.184.184.184.184.184.184.184.184.184.424.424.424.424.424.424.424.424.42
---------------------
Details

Keystats

ⓘ

Revenue and Growth

The Medicon Hellas Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Medicon Hellas is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (k)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (k)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
200220032004200520062007200820092010201120122013201420152016201720182019202020212022
                                         
000.010.010.010.240.822.030.010.010.011.973.162.394.044.426.226.077.210.3610.21
14.2521.8531.0321.0628.4637.3744.6952.2120.717.7817.9210.5810.1612.8112.2310.137.326.875.547.528.26
560860980000000000000000000
2.43.642.762.382.553.73.93.483.272.752.492.462.512.362.632.642.993.243.422.612.77
90120220000000-1,280-1,2800000000000
17.326.473523.4531.0241.3149.4157.7223.9819.2619.1415.0115.8317.5618.917.216.5316.1816.1620.4921.24
5.215.886.135.75.475.264.944.734.826.26.15.324.994.784.925.275.437.757.827.246.69
3.551.030.780.450.810.180.290.328.617.915.382.962.122.282.451.500000
24024022030303030202030302086.31068.8667.7893.850.9555.1660.2663.37
16029031053040030023018017014012010095.0786.7285.9676.3568.5659.3165.9261.1355.86
000000000000000000000
0.420.260.180.120.110.230.390.550.643.95.034.835.015.725.75.2743.372.922.722.57
9.587.77.626.836.8265.885.7834.2618.1816.6613.2312.3112.8813.2212.199.5911.2410.8710.099.38
26.8834.1742.6230.2837.8447.3155.2963.558.2437.4435.828.2428.1330.4432.1229.3926.1227.4227.0230.5830.63
                                         
5.745.746.316.316.66.66.66.66.66.66.66.66.986.986.986.986.986.986.986.986.98
760760180180170170170170170170170170173.1173.1173.1173.1173.1173.1173.1173.1173.1
5.056.867.559.579.579.99.9810.578.63-4.01-4.43-3.97-3.87-2.2-1.040.682.523.14.127.199.8
5060280000000000000000000
000000000000000000000
11.613.4214.3216.0616.3416.6716.7517.3415.42.762.342.83.294.966.127.849.6810.2611.2714.3416.95
1.331.11.111.492.182.762.822.242.742.872.362.712.732.842.922.231.571.612.552.472.53
15030026000002602402802600000000000
3.263.523.360.471.030.761.050.861.220.660.8700000.420.430.520.31.230.31
8.5611.7520.5310.8716.8510.6126.0935.327.9422.890.050000000.480.310.310.31
0.121.081.02000000031.0823.1421.9122.3422.9718.980.810.490.750.740.54
13.4217.7526.2812.8320.0614.1329.9638.6632.1426.734.6225.8524.6425.1725.8921.632.813.13.914.743.69
0.061.50.50015.0187.1211.8610.600000013.4813.8112.2611.0710.18
000000000000045.1945.19109.6993.258.6747.9766.3123.15
1.661.611.740.610.560.640.780.710.840.760.830.320.490.460.530.610.620.70.360.380.31
1.723.112.240.610.5615.658.787.8312.711.360.830.320.490.510.570.7214.1914.5712.6711.5210.61
15.1420.8628.5213.4420.6229.7838.7446.4944.8438.0635.4526.1725.1225.6826.4622.361717.6716.5816.2614.3
26.7434.2842.8429.536.9646.4555.4963.8360.2440.8237.7928.9728.4130.6432.5830.1926.6827.9327.8530.6131.25
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Medicon Hellas provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Medicon Hellas's financial health and stability.

Assets

Medicon Hellas's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Medicon Hellas must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Medicon Hellas after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Medicon Hellas's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (k)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2004200520062007200820092010201120122013201420152016201720182019202020212022
4232120-15-10011231143
000000001,0001,0001,00000001,0001,0001,0001,000
0000000000000000000
-118-83-10-1018-250-3-11000-2-3
000110318210110-10000
0001111221100000000
1,00001,0000000000000000001,000
-512-47-6-641109101431341
-1000000-1-1000000-1000
0000000-10000003-1000
0000000010000030000
0000000000000000000
7-116-688-2-8-2-8000-4-40-1-1-1
0000000000000000000
6-125-766-3-9-2-8000-4-40-1-1-1
-------------------
-1-1-1-1-1-1-1000000000000
00000101-21101010130
-6.7612.46-4.767.31-6.57-6.714.059.88-1.89.181.57-0.431.754.72.59-0.272.344.240.84
0000000000000000000

Medicon Hellas stock margins

The Medicon Hellas margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medicon Hellas. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medicon Hellas.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medicon Hellas's sales revenue. A higher gross margin percentage indicates that the Medicon Hellas retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medicon Hellas's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medicon Hellas's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medicon Hellas's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medicon Hellas. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medicon Hellas's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medicon Hellas Margin History

Medicon Hellas Gross marginMedicon Hellas Profit marginMedicon Hellas EBIT marginMedicon Hellas Profit margin
202274.52 %18.46 %12.2 %
202172.94 %22.94 %14.14 %
202073.9 %10.43 %4.96 %
201975.68 %8.15 %5.76 %
201876.06 %16.29 %13.29 %
201777.53 %15.3 %13.52 %
201676.3 %22.11 %8.96 %
201578.06 %20.93 %14.62 %
201479.56 %13.58 %6.34 %
201376.84 %17.46 %0.79 %
201275.83 %6.98 %-4.51 %
201177.68 %17.3 %-79.58 %
201075.57 %17.9 %-4.79 %
200973.61 %19.68 %10.12 %
200870.82 %19.5 %6.79 %
200772.09 %20.51 %8.18 %
200670.18 %21.22 %8.44 %
200573.03 %19.69 %8.45 %
200466.9 %20.24 %7.91 %
200373.51 %27.18 %17.29 %

Medicon Hellas Stock Sales Revenue, EBIT, Earnings per Share

The Medicon Hellas earnings per share therefore indicates how much revenue Medicon Hellas has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Medicon Hellas earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medicon Hellas's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medicon Hellas’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medicon Hellas's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medicon Hellas Revenue, EBIT and net profit per share

DateMedicon Hellas Sales per ShareMedicon Hellas EBIT per shareMedicon Hellas Earnings per Share
20224.7 undefined0.87 undefined0.57 undefined
20214.87 undefined1.12 undefined0.69 undefined
20203.45 undefined0.36 undefined0.17 undefined
20193.04 undefined0.25 undefined0.18 undefined
20183.12 undefined0.51 undefined0.41 undefined
20172.87 undefined0.44 undefined0.39 undefined
20162.94 undefined0.65 undefined0.26 undefined
20152.59 undefined0.54 undefined0.38 undefined
20142.5 undefined0.34 undefined0.16 undefined
20132.73 undefined0.48 undefined0.02 undefined
20122.81 undefined0.2 undefined-0.13 undefined
20113.53 undefined0.61 undefined-2.81 undefined
20103.85 undefined0.69 undefined-0.18 undefined
20094.35 undefined0.86 undefined0.44 undefined
20084.72 undefined0.92 undefined0.32 undefined
20074.62 undefined0.95 undefined0.38 undefined
20064.36 undefined0.93 undefined0.37 undefined
20054.3 undefined0.85 undefined0.36 undefined
20044.54 undefined0.92 undefined0.36 undefined
20034.14 undefined1.12 undefined0.72 undefined

Medicon Hellas business model

Medicon Hellas is one of the most popular companies on Eulerpool.com.

Medicon Hellas Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Medicon Hellas historical P/E ratio, EBIT, and P/S ratio.

Medicon Hellas shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Medicon Hellas earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medicon Hellas's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medicon Hellas’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medicon Hellas's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medicon Hellas Stock splits

In Medicon Hellas's history, there have been no stock splits.

Medicon Hellas dividend payout ratio

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Medicon Hellas represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Medicon Hellas could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Medicon Hellas's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Medicon Hellas Payout Ratio History

DateMedicon Hellas Payout ratio
202278.49 %
202178.54 %
202078.43 %
201978.51 %
201878.67 %
201778.11 %
201678.76 %
201579.15 %
201476.41 %
201380.74 %
201280.29 %
2011-7.83 %
2010-157.89 %
200968.18 %
200893.75 %
200778.95 %
200681.08 %
200591.67 %
200488.39 %
200344.19 %
Unfortunately, there are currently no price targets and forecasts available for Medicon Hellas.

Medicon Hellas list of shareholders

%
Name
Stocks
Change
Date
16.01997 % Pikramenou (Maria)708,02202/12/2024
14.35999 % Dimotsantos (George)634,65702/12/2024
14.35999 % Dimotsantou (Maria Eleni)634,65702/12/2024
0.09051 % Optima Asset Management A.E.D.A.K4,000012/31/2023
1

Most common questions regarding Medicon Hellas

What is the P/E ratio of Medicon Hellas 2024?

The P/E ratio cannot be calculated for Medicon Hellas at the moment.

What is the P/S ratio of Medicon Hellas 2024?

The P/S cannot be calculated for Medicon Hellas currently.

What is the AlleAktien quality score of Medicon Hellas?

The AlleAktien quality score for Medicon Hellas is 5/10.

What is the revenue of Medicon Hellas 2024?

The revenue cannot currently be calculated for Medicon Hellas.

How high is the profit of Medicon Hellas 2024?

The profit cannot currently be calculated for Medicon Hellas.

What is the business model of Medicon Hellas

No history available for Medicon Hellas.

What is the Medicon Hellas dividend?

Medicon Hellas pays a dividend of 0 EUR distributed over payouts per year.

How often does Medicon Hellas pay dividends?

The dividend cannot currently be calculated for Medicon Hellas or the company does not pay out a dividend.

What is the Medicon Hellas ISIN?

The ISIN of Medicon Hellas is GRS424003002.

What is the Medicon Hellas ticker?

The ticker of Medicon Hellas is MEDIC.AT.

How much dividend does Medicon Hellas pay?

Over the past 12 months, Medicon Hellas paid a dividend of 0.22 EUR . This corresponds to a dividend yield of about 8.84 %. For the coming 12 months, Medicon Hellas is expected to pay a dividend of 0 EUR.

What is the dividend yield of Medicon Hellas?

The current dividend yield of Medicon Hellas is 8.84 %.

When does Medicon Hellas pay dividends?

Medicon Hellas pays a quarterly dividend. This is distributed in the months of August, April, August, August.

How secure is the dividend of Medicon Hellas?

Medicon Hellas paid dividends every year for the past 0 years.

What is the dividend of Medicon Hellas?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medicon Hellas located?

Medicon Hellas is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medicon Hellas kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medicon Hellas from 7/19/2024 amounting to 0.06 EUR, you needed to have the stock in your portfolio before the ex-date on 7/15/2024.

When did Medicon Hellas pay the last dividend?

The last dividend was paid out on 7/19/2024.

What was the dividend of Medicon Hellas in the year 2023?

In the year 2023, Medicon Hellas distributed 0 EUR as dividends.

In which currency does Medicon Hellas pay out the dividend?

The dividends of Medicon Hellas are distributed in EUR.

All fundamentals about Medicon Hellas

Our stock analysis for Medicon Hellas Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medicon Hellas Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.